We are live on
!
Find out more
SKP
Sanborn Kilcollin Partners Portfolio holdings
AUM
$143M
1-Year Est. Return
19.16%
This Fund
S&P 500
This Quarter
Est. Return
+6.22%
1 Year Est. Return
+19.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$217M
AUM Growth
+$18.7M
(+9.4%)
Cap. Flow
+$15.7M
Cap. Flow
% of AUM
7.23%
Top 10 Holdings %
Top 10 Hldgs %
69.61%
Holding
19
New
–
Increased
17
Reduced
2
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$27.6M |
| 2 |
Masco
MAS
|
+$324K |
| 3 |
PepsiCo
PEP
|
+$149K |
| 4 |
APA Corp
APA
|
+$141K |
| 5 |
Microsoft
MSFT
|
+$138K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Devon Energy
DVN
|
+$9.33M |
| 2 |
Intel
INTC
|
+$4.25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 31.22% |
| 2 | Healthcare | 24.65% |
| 3 | Technology | 16.46% |
| 4 | Energy | 16.33% |
| 5 | Industrials | 8.01% |
Similar funds
AHC
COPM
RH
AAA
WLC
J
PIP
CIP
Sanborn Kilcollin Partners's Q2 2014 Portfolio in Review
As of Q2 2014, Sanborn Kilcollin Partners held 19 positions worth $217M, up 9.4% from $198M the previous quarter. Its ten largest holdings account for 70% of the portfolio.
Sanborn Kilcollin Partners deployed $15.7M of net new capital in Q2 2014, adding to 17 existing holdings.
By sector, the portfolio is most concentrated in Consumer Staples at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Devon Energy, an estimated $9.33M trimmed.
- Sanborn Kilcollin Partners added most to Johnson & Johnson in Q2 2014, an estimated $27.6M increase.
- Sanborn Kilcollin Partners's biggest Q2 2014 reduction was Devon Energy, cutting an estimated $9.33M.
- Sanborn Kilcollin Partners's ten largest holdings make up 70% of its $217M portfolio in Q2 2014.
- Sanborn Kilcollin Partners opened 0 new positions and closed 0 in Q2 2014.
- Sanborn Kilcollin Partners's portfolio value rose 9.4% quarter-over-quarter to $217M.
Based on Sanborn Kilcollin Partners's 13F filing for Q2 2014, filed 13 Aug 2014.